AP
Alnylam Pharmaceuticals, Inc. - Common Stock
ALNY
Close · 12/10/2026
227.02
1D
-2.43%52-week range
197.81 – 495.55
Volume
9,16,900.00
Price history
ALNY
11/09/2026 to 12/10/2026
O 233.13 H 233.60 L 226.35
1W+3.24%
1M-8.71%
3M-19.28%
6M-31.83%
1Y-50.32%
3Y+27.03%
5Y+16.41%
MAX+13.37%
Fundamentals
as of 12/10/2026- Market cap
- $30.38B
- Shares out
- 133.81M
- P/E (trailing)
- 39.21
- P/E (forward)
- 18.73
- EPS (trailing)
- 5.79
- Dividend yield
- 0.00%
- Beta
- 0.27
- Profit margin
- 21.30%
- P/B
- 22.43
- Return on equity
- 57.21%
SEC financial statements
62 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- ALNY
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 12/10/2026.
Tracked by Congress
5 filers · 1 on watchlist · 4 buys · 4 sells · ?: 3 · D: 4 · R: 1
- 11/08/2026Cory A BookerSellAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/05/2025Jefferson ShreveSellAlnylam Pharmaceuticals, Inc. - Common Stock$15,001–$50,000
- 29/01/2024Josh GottheimerWSellAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/01/2024Josh GottheimerWBuyAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/12/2023Josh GottheimerWSellAlnylam Pharmaceuticals, Inc.$1,001–$15,000
- 06/03/2023Daniel GoldmanBuyAlnylam Pharmaceuticals, Inc.$15,001–$50,000
- 28/09/2022Josh GottheimerWBuyAlnylam Pharmaceuticals, Inc.$1,001–$15,000
- 13/10/2016Richard L. HannaBuyAlnylam Pharmaceuticals, Inc. (ALNY) FILINg STATUS: New SUbHoLDINg oF: RHIRA$100,001–$250,000